Comparative assessment of clinical rating scales in Wilson’s disease

Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism resulting in multifaceted neurological, hepatic, and psychiatric symptoms. The objective of the study was to comparatively assess two clinical rating scales for WD, the Unified Wilson’s Disease Rating Scale (UWDRS) and the...

Full description

Saved in:
Bibliographic Details
Main Authors: Volpert, Hanna Maria (Author) , Pfeiffenberger, Jan (Author) , Gröner, Jan (Author) , Stremmel, Wolfgang (Author) , Gotthardt, Daniel (Author) , Schäfer, Mark (Author) , Weiss, Karl Heinz (Author) , Weiler, Markus (Author)
Format: Article (Journal)
Language:English
Published: 21 July 2017
In: BMC neurology
Year: 2017, Volume: 17
ISSN:1471-2377
DOI:10.1186/s12883-017-0921-3
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12883-017-0921-3
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12883-017-0921-3
Get full text
Author Notes:Hanna M. Volpert, Jan Pfeiffenberger, Jan B. Gröner, Wolfgang Stremmel, Daniel N. Gotthardt, Mark Schäfer, Karl Heinz Weiss and Markus Weiler
Description
Summary:Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism resulting in multifaceted neurological, hepatic, and psychiatric symptoms. The objective of the study was to comparatively assess two clinical rating scales for WD, the Unified Wilson’s Disease Rating Scale (UWDRS) and the Global Assessment Scale for Wilson’s disease (GAS for WD), and to test the feasibility of the patient reported part of the UWDRS neurological subscale (termed the “minimal UWDRS”).
Item Description:Gesehen am 21.09.2017
Physical Description:Online Resource
ISSN:1471-2377
DOI:10.1186/s12883-017-0921-3